JPRN-UMIN000034251已完成未知
Prediction of the pharmacokinetics and adverse events of glecaprevir/pibrentasvir in patients with hepatitis C virus by gadoxetic acid enhanced magnetic resonance imaging - Prediction of the PKs and AEs of GLE/PIB by EOB-MRI
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Hypersensitivity to Gd-EOB-DTPA 2) Estimated glomerular filtration rate under 40ml/min/1.73m2
研究者
相似试验
招募中
不适用
Prediction of the pharmacokinetics and adverse events of nab-paclitaxel in patients with pancreatic cancer by magnetic resonance imagingnresectable locally advanced pancreatic cancer or metastatic pancreatic cancerJPRN-UMIN000026180Juntendo University40
已完成
不适用
Prediction of the pharmacokinetics and adverse events of paritaprevir in patients with hepatitis C virus by magnetic resonance imagingType C chronic hepatitis or type C liver cirrhosisJPRN-UMIN000022587Juntendo University Nerima Hospital Department of Gastroenterology30
进行中（未招募）
1 期
Metabolism and effects of naloxone given as a spray in healthy volunteers and children.Sedation after opioid administrationPharmacokinetic profile after naloxone administered intranasallyEUCTR2013-005201-31-SEKarolinska University Hospital20
招募中
1 期
Phase 1 study of 211At-MABG in patients with pheochromocytoma/pargangliomaPheochromocytoma, paragangliomaD010673, D010235JPRN-jRCT2021220012Shiga Tohru18
已完成
不适用
Study of blood level of lifesaving antibiotic meropenum in serious ICU patients in relation to blood level that kills bacteria.CTRI/2013/07/003850Tata Memorial Hospital25